| Reportable Segment Information |
The tables below present information about our reportable segments:
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
|
April 30, |
|
|
April 30, |
|
|
(in millions) |
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
|
Product revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Imaging |
|
$ |
68.2 |
|
|
$ |
71.9 |
|
|
$ |
205.9 |
|
|
$ |
208.7 |
|
|
Ultrasound |
|
|
34.8 |
|
|
|
36.8 |
|
|
|
110.7 |
|
|
|
115.9 |
|
|
Security and Detection |
|
|
17.8 |
|
|
|
17.6 |
|
|
|
54.8 |
|
|
|
41.8 |
|
|
Total product revenue |
|
$ |
120.8 |
|
|
$ |
126.3 |
|
|
$ |
371.4 |
|
|
$ |
366.4 |
|
|
Engineering revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Imaging |
|
$ |
1.3 |
|
|
$ |
0.9 |
|
|
$ |
3.1 |
|
|
$ |
2.6 |
|
|
Ultrasound |
|
|
- |
|
|
|
0.8 |
|
|
|
0.2 |
|
|
|
1.7 |
|
|
Security and Detection |
|
|
0.1 |
|
|
|
(0.1 |
) |
|
|
0.1 |
|
|
|
0.1 |
|
|
Total engineering revenue |
|
$ |
1.4 |
|
|
$ |
1.6 |
|
|
$ |
3.4 |
|
|
$ |
4.4 |
|
|
Net revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Imaging |
|
$ |
69.5 |
|
|
$ |
72.9 |
|
|
$ |
209.0 |
|
|
$ |
211.3 |
|
|
Ultrasound |
|
|
34.8 |
|
|
|
37.6 |
|
|
|
110.9 |
|
|
|
117.6 |
|
|
Security and Detection |
|
|
17.9 |
|
|
|
17.5 |
|
|
|
54.9 |
|
|
|
41.9 |
|
|
Total net revenue |
|
$ |
122.2 |
|
|
$ |
128.0 |
|
|
$ |
374.8 |
|
|
$ |
370.8 |
|
|
Income (loss) from operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Imaging (A) |
|
$ |
12.2 |
|
|
$ |
10.2 |
|
|
$ |
31.3 |
|
|
$ |
28.2 |
|
|
Ultrasound (B) |
|
|
(79.3 |
) |
|
|
(5.0 |
) |
|
|
(89.7 |
) |
|
|
(19.5 |
) |
|
Security and Detection (C ) |
|
|
2.5 |
|
|
|
2.4 |
|
|
|
7.2 |
|
|
|
2.4 |
|
|
Total (loss) income from operations |
|
|
(64.6 |
) |
|
|
7.6 |
|
|
|
(51.2 |
) |
|
|
11.1 |
|
|
Total other income (loss), net |
|
|
0.10 |
|
|
|
(0.9 |
) |
|
|
(0.4 |
) |
|
|
(4.9 |
) |
|
(Loss) income before income taxes |
|
$ |
(64.5 |
) |
|
$ |
6.7 |
|
|
$ |
(51.6 |
) |
|
$ |
6.2 |
|
|
|
|
As of |
|
|
As of |
|
|
|
|
April 30, |
|
|
July 31, |
|
|
(in millions) |
|
2017 |
|
|
2016 |
|
|
Identifiable total assets by segment: |
|
|
|
|
|
|
|
|
|
Medical Imaging |
|
$ |
182.8 |
|
|
$ |
191.1 |
|
|
Ultrasound |
|
|
146.8 |
|
|
|
152.5 |
|
|
Security and Detection |
|
|
42.6 |
|
|
|
49.8 |
|
|
Total reportable segment assets |
|
|
372.2 |
|
|
|
393.4 |
|
|
Corporate assets (D) |
|
|
193.1 |
|
|
|
165.6 |
|
|
Total identifiable assets |
|
$ |
565.3 |
|
|
$ |
559.0 |
|
|
(A) |
Includes restructuring charges of $0.2 million and $1.1 million for three months ended April 30, 2017 and April 30, 2016, respectively and $0.4 million and $5.1 million for nine months ended April 30, 2017 and April 30, 2016. |
|
(B) |
Includes restructuring charges of $1.8 million and $0.4 million for three months ended April 30, 2017 and April 30, 2016, respectively and $1.9 million and $1.7 million for nine months ended April 30, 2017 and April 30, 2016. |
Includes contingent consideration charges of $(2.1) million and $(10.2) million related to Oncura for three and nine months ended April 30, 2017, respectively. Includes asset impairment charges of $3.1 million related to Oncura intangible assets for three and nine months ended April 30, 2017. Includes asset impairment charges of $8.1 million related to PocketSonics intangible assets for three and nine months ended April 30, 2017. Includes goodwill impairment charges of $6.7 million and $16.5 million related to Oncura reporting unit for three and nine months ended April 30, 2017. Includes goodwill impairment charges of $55.1 million related to Ultrasound reporting unit for three and nine months ended April 30, 2017. Includes charges for the BK Medical matter of $0.0 million and $10.1 million for three and nine months ended April 30, 2016 .
|
(C) |
Includes restructuring charges of $0.1 million and $0.3 million for three months ended April 30, 2017 and April 30, 2016, respectively and $0.1 million and $1.5 million for nine months ended April 30, 2017 and April 30, 2016. |
Includes asset impairment charges of $0.0 million and $0.6 million related to Pathfinder for three and nine months ended April 30, 2017.
|
(D) |
Includes cash and cash equivalents of $144.9 million and $97.3 million as of April 30, 2017 and July 31, 2016, respectively. |
|